Breast Implant Adverse Events During Mammography An FDA study on problems with mammography for women with breast implants was published in the Journal of Women’s Health in May, 2004. The preliminary results of this study were presented at the FDA Science Forum in April, 2003 more...

Vitamin D2 supplements may help prevent falls among high-risk older women Vitamin D2 supplements appear to reduce the risk of falls among women with a history of falling and low blood vitamin D levels living in sunny climates, especially during the winter. more...

C-section: When is it the best option? Caesarean birth — also known as a C-section — is the birth of a baby through an incision in the mother's abdomen. Although C-sections are sometimes planned due to pregnancy complications or previous C-sections, most first-time C-sections occur unexpectedly. Why is C-section sometimes needed? more...

Women on psychiatric medications who want to get pregnant should follow these guidelines in consultation with a physician Women with a psychiatric history may wonder about the risks associated with pregnancy and parenthood. A safe pregnancy for mother and baby is often possible, but it is vital for the woman to work closely with a knowledgeable physician. Symptoms of many psychiatric conditions (depression, mania, panic, and even schizophrenia) frequently seem relatively inactive during pregnancy. Medications may be necessary, however, and some are less risky than others. more...

Bone Mineral Density and the Risk of Incident Nonspinal Fractures in Black and White Women Decreased total hip and femoral neck BMD is associated with an increased risk of fracture in both older black and white women, but this relationship was largely explained by other risk factors in black women. Black women have a lower fracture risk than white women at every level of BMD. Race-specific normative databases may be appropriate for the densitometric definition of osteoporosis. more...

Raloxifene therapy for 4 years significantly reduce the risk of cardiovascular events in the subset of women with increased cardiovascular risk. Raloxifene therapy for 4 years did not significantly affect the risk of cardiovascular events in the overall cohort but did significantly reduce the risk of cardiovascular events in the subset of women with increased cardiovascular risk. There was no evidence that raloxifene caused an early increase in risk of cardiovascular events. Before raloxifene is used for prevention of cardiovascular events, these findings require confirmation in trials with evaluation of cardiovascular outcomes as the primary objective. more...

Office of Research on Women's Health (ORWH)

elogIQ's IQue Get 50% off on elogIQ's IQue - a logic and memory game for young and old. Use code sr101